Leuthold Group, LLC Novartis Ag Transaction History

Leuthold Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$80.03 - $92.81 $22,088 - $25,615	-276 Reduced 5.41%	4,824 $443,000
Q4 2022 Jan 31, 2023	SELL	$75.55 - $92.52 $6,572 - $8,049	-87 Reduced 1.68%	5,100 $463,000
Q2 2022 Aug 01, 2022	BUY	$80.52 - $93.75 $417,657 - $486,281	5,187 New	5,187 $438,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $433,600 - $524,464	-5,554 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $12,649 - $14,014	-154 Reduced 2.7%	5,554 $483,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $18,128 - $20,406	-224 Reduced 3.78%	5,708 $499,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $38,939 - $54,554	-551 Reduced 8.5%	5,932 $489,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $546,841 - $618,283	6,483 New	6,483 $614,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.